Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001349486 | SCV001543834 | benign | Adams-Oliver syndrome 5 | 2023-10-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001527334 | SCV001738305 | uncertain significance | not provided | 2022-06-29 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function |
Genome- |
RCV001349486 | SCV002553933 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271224 | SCV002553934 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413825 | SCV002716129 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-03-18 | criteria provided, single submitter | clinical testing | The c.1750G>A (p.V584I) alteration is located in exon 11 (coding exon 11) of the NOTCH1 gene. This alteration results from a G to A substitution at nucleotide position 1750, causing the valine (V) at amino acid position 584 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |